CBD interestingmedicinal properties. This compound has generated increasing interest due to its promising effects in treating various conditions, including anxiety, pain, inflammation, and nausea. In this article, we will discuss the interactions between CBD and lansoprazole, a medication commonly used to treat stomach problems such as gastroesophageal reflux disease (GERD), gastritis, and stomach ulcers.
Summary
ToggleLansoprazole-based medications: Prevacid, Lanzor and Lansoprazole-ratiopharm
Lansoprazole of medications called proton pump inhibitors (PPIs). It works by reducing the production of stomach acid by the cells lining the stomach. Some medications containing lansoprazole on the market include:
- Prevacid, available as capsules or orally disintegrating tablets,
- Lanzor, available in capsule form in various dosages,
- and Lansoprazole-ratiopharm, marketed in delayed-release capsules.
These medications are indicated for treating various stomach-related disorders, such as gastric and duodenal ulcers, gastroesophageal reflux disease (GERD), and gastritis. They can be prescribed for short-term or long-term treatment, depending on the condition being treated and its progression.
CBD: a natural substance with numerous therapeutic benefits
Cannabidiol, a molecule derived from cannabis plants, better known as CBD, has become the subject of much scientific research due to its interesting medical properties:
- Pain relief,
- Reduction of inflammation,
- Reduction of anxiety and stress,
- Sleep improvement ,
- Beneficial action on certain neurological disorders such as epilepsy and multiple sclerosis.
Because CBD has numerous effects, it is being used by more and more people worldwide. It can be consumed in various ways, such as orally, by inhalation, topically, etc.
Interactions between CBD and lansoprazole: what do the studies say?
Drug interactions are a crucial issue for patients and healthcare professionals to ensure effective and safe treatment. It is essential to check for potential interactions between two substances before combining them, whether they are medications or dietary supplements.
To date, few studies have addressed the interaction between CBD and proton pump inhibitors such as lansoprazole. However, it is known that CBD can be metabolized by liver enzymes, particularly cytochrome P450. This same enzyme is responsible for the breakdown of other substances, including certain medications.
A possible interaction via cytochrome P450
In this context, there is a theoretical risk that CBD could affect the action or side effects of drugs metabolized by cytochrome P450. Regarding lansoprazole, it has been observed that it is partially metabolized via this hepatic pathway.
Therefore, the concomitant use of CBD and lansoprazole may alter the elimination and/or activity of either compound in the body. In practice, this could result in a decrease or increase in the effectiveness of the treatments, as well as the occurrence of potential side effects.
Precautions to take when combining CBD and lansoprazole
In the absence of concrete data on the interactions between CBD and lansoprazole, caution should be exercised when these substances are used together. It is recommended to:
- Inform your doctor or pharmacist about taking CBD and lansoprazole so they can assess whether this combination presents a health risk
- Inform the healthcare professional responsible for monitoring your treatment of any changes in your health status
- Carefully follow the prescribed dosage and do not hesitate to seek advice if you have any doubts
- Be attentive to signs of overdose or unusual side effects.
Thus, although information available is still limited regarding the possible interaction between CBD and lansoprazole, it remains important to be vigilant and consult a healthcare professional before undertaking such a therapeutic combination.
Co-founder of CBD.fr
Julien Cordobes is the editor of CBD.fr. Born in 1978 in the Paris region, he first trained in e-commerce before turning to natural health approaches, a dual perspective that now structures his way of writing about cannabidiol: reading the scientific literature as it is, without hardening the conclusions, and presenting it in a language that everyone understands.
He discovered CBD at a time when the French market was developing faster than the information available to it. He acquired CBD.fr in 2022 and then took on editorial responsibility for the blog. Since then, he has published numerous articles covering the daily use of CBD, the interpretation of laboratory analyses, the evolution of the legal framework, and precautions for use.